{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:02:32Z","timestamp":1773788552647,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05441-z","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T14:02:08Z","timestamp":1694786528000},"page":"2211-2220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-4202","authenticated-orcid":false,"given":"Suhrud","family":"Panchawagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1650-8928","authenticated-orcid":false,"given":"Doskaliuk","family":"Bohdana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-6136","authenticated-orcid":false,"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-1637","authenticated-orcid":false,"given":"Akira","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keina","family":"Yomono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-2364","authenticated-orcid":false,"given":"John D.","family":"Pauling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-898X","authenticated-orcid":false,"given":"Ashima","family":"Makol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8739-4502","authenticated-orcid":false,"given":"Esha","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-4361","authenticated-orcid":false,"given":"Jessica","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-851X","authenticated-orcid":false,"given":"Tulika","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8952-5967","authenticated-orcid":false,"given":"Wanruchada","family":"Katchamart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7611-9992","authenticated-orcid":false,"given":"Phonpen Akarawatcharangura","family":"Goo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-3726","authenticated-orcid":false,"given":"Elena","family":"Nikiphorou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1630-6026","authenticated-orcid":false,"given":"Parikshit","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3339-5112","authenticated-orcid":false,"given":"Dzifa","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3292-1528","authenticated-orcid":false,"given":"Lorenzo","family":"Cavagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-7049","authenticated-orcid":false,"given":"Carlos Enrique Toro","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0986-8354","authenticated-orcid":false,"given":"Vishwesh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-8768","authenticated-orcid":false,"given":"Marcin","family":"Milchert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-7678","authenticated-orcid":false,"given":"Nelly","family":"Ziade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-8310","authenticated-orcid":false,"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"COVAD Study","family":"Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-1288","authenticated-orcid":false,"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7531-8038","authenticated-orcid":false,"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"issue":"3","key":"5441_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","volume":"80","author":"S Akiyama","year":"2021","unstructured":"Akiyama S, Hamdeh S, Micic D, Sakuraba A (2021) Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis [Internet]. 80(3):384\u2013391 (cited 2023 Apr 13)","journal-title":"Ann Rheum Dis [Internet]."},{"issue":"7","key":"5441_CR2","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s10067-020-05193-2","volume":"39","author":"M Orlandi","year":"2020","unstructured":"Orlandi M, Lepri G, Bruni C, Wang Y, Bartoloni A, Zammarchi L et al (2020) The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress. Clin Rheumatol [Internet]. 39(7):2043 (cited 2023 Apr 13)","journal-title":"Clin Rheumatol [Internet]."},{"issue":"8","key":"5441_CR3","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1016\/S2665-9913(22)00130-8","volume":"4","author":"AM Hoffmann-Vold","year":"2022","unstructured":"Hoffmann-Vold AM, Distler O, Bruni C, Denton CP, de Vries-Bouwstra J, MatucciCerinic M et al (2022) Systemic sclerosis in the time of COVID-19. Lancet Rheumatol [Internet]. 4(8):e566 (cited 2023 Apr 13)","journal-title":"Lancet Rheumatol [Internet]."},{"issue":"5","key":"5441_CR4","first-page":"e21","volume":"74","author":"JR Curtis","year":"2022","unstructured":"Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR et al (2022) American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 4. Arthritis Rheumatol [Internet]. 74(5):e21 (cited 2023 Apr 13)","journal-title":"Arthritis Rheumatol [Internet]."},{"key":"5441_CR5","doi-asserted-by":"crossref","unstructured":"Beydon M, Chevalier K, Al Tabaa O, Hamroun S, Delettre AS, Thomas M et al (2021) Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis [Internet] 80(3). https:\/\/pubmed.ncbi.nlm.nih.gov\/32327427\/(cited 2023 Apr 13)","DOI":"10.1136\/annrheumdis-2020-217573"},{"key":"5441_CR6","doi-asserted-by":"crossref","unstructured":"Saud A, Naveen R, Aggarwal R, Gupta L (2021) COVID-19 and myositis: what we know so far. Curr Rheumatol Rep [Internet] 23(8). https:\/\/pubmed.ncbi.nlm.nih.gov\/34216297\/(cited 2023 Apr 13)","DOI":"10.1007\/s11926-021-01023-9"},{"issue":"4","key":"5441_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/mus.27681","volume":"66","author":"A Gil-Vila","year":"2022","unstructured":"Gil-Vila A, Ravichandran N, Selva-O\u2019Callaghan A, Sen P, Nune A, Gaur PS et al (2022) COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle Nerve [Internet] 66(4):426\u2013437. https:\/\/doi.org\/10.1002\/mus.27681","journal-title":"Muscle Nerve [Internet]"},{"key":"5441_CR8","unstructured":"Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB et al (2022) Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology (Oxford) [Internet] https:\/\/pubmed.ncbi.nlm.nih.gov\/36282492\/(cited 2023 Apr 13)"},{"issue":"12","key":"5441_CR9","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00296-022-05157-6","volume":"42","author":"ZZ Fazal","year":"2022","unstructured":"Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V et al (2022) COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatol Int [Internet] 42(12):2151\u20132158. https:\/\/doi.org\/10.1007\/s00296-022-05157-6. (cited 2023 Apr 13)","journal-title":"Rheumatol Int [Internet]"},{"key":"5441_CR10","doi-asserted-by":"crossref","unstructured":"Eysenbach G (2004) Improving the Quality of Web Surveys: The checklist for reporting results of Internet E-surveys (CHERRIES). J Med Internet Res 2004;6(3):e34 https:\/\/www.jmir.org\/2004\/3\/e34 [Internet]. 2004 [cited 2023 Apr 13];6(3):e132. https:\/\/www.jmir.org\/2004\/3\/e34","DOI":"10.2196\/jmir.6.3.e34"},{"key":"5441_CR11","doi-asserted-by":"crossref","unstructured":"Cuschieri S (2019) The STROBE guidelines. Saudi J Anaesth [Internet] 13(Suppl 1):S31\u2013S34. https:\/\/pubmed.ncbi.nlm.nih.gov\/30930717\/(cited 2023 Apr 13)","DOI":"10.4103\/sja.SJA_543_18"},{"key":"5441_CR12","unstructured":"Patient-Reported Outcomes Measurement Information System (PROMIS)|National Institute on Aging [Internet]. https:\/\/www.nia.nih.gov\/research\/resource\/patient-reported-outcomes-measurement-information-system-promis(cited 2023 Apr 13)"},{"key":"5441_CR13","unstructured":"Naveen R, Parodis I, Joshi M, Sen P, Lindblom J, Agarwal V et al (2022) COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis. Rheumatology (Oxford) [Internet]. https:\/\/pubmed.ncbi.nlm.nih.gov\/36315075\/(cited 2023 Apr 13)"},{"issue":"4","key":"5441_CR14","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1016\/S2665-9913(21)00416-1","volume":"4","author":"JK Gordon","year":"2022","unstructured":"Gordon JK, Showalter K, Wu Y, Kwakkenbos L, Carrier ME, Henry RS et al (2022) Systemic sclerosis and COVID-19 vaccines: a SPIN cohort study. Lancet Rheumatol [Internet] 4(4):e243 (cited 2023 Apr 13)","journal-title":"Lancet Rheumatol [Internet]"},{"issue":"7","key":"5441_CR15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S, Al-Adely S, Carmona L, Danila MI et al (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis [Internet] 79(7):859\u2013866 (cited 2023 Apr 15)","journal-title":"Ann Rheum Dis [Internet]"},{"issue":"5","key":"5441_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med [Internet] 384(5):403\u2013416 (cited 2023 Apr 15)","journal-title":"N Engl J Med [Internet]"},{"issue":"27","key":"5441_CR17","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S et al (2020) Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med [Internet] 383(27):2603\u20132615 (cited 2023 Apr 15)","journal-title":"N Engl J Med [Internet]"},{"issue":"10269","key":"5441_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(20)32623-4","volume":"397","author":"MD Knoll","year":"2021","unstructured":"Knoll MD, Wonodi C (2021) Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet [Internet] 397(10269):72\u201374 (cited 2023 Apr 15)","journal-title":"Lancet [Internet]"},{"issue":"2","key":"5441_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/rheumatology\/ken455","volume":"48","author":"SB Sandusky","year":"2009","unstructured":"Sandusky SB, McGuire L, Smith MT, Wigley FM (2009) Haythornthwaite JA (2009) Fatigue: an overlooked determinant of physical function in scleroderma. Rheumatology (Oxford) [Internet] 48(2):165 (cited 2023 Apr 13)","journal-title":"Rheumatology (Oxford) [Internet]"},{"issue":"6","key":"5441_CR20","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/jmv.27655","volume":"94","author":"SP Parida","year":"2022","unstructured":"Parida SP, Sahu DP, Singh AK, Alekhya G, Subba SH, Mishra A et al (2022) Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India. J Med Virol [Internet] 94(6):2453 (cited 2023 Apr 13)","journal-title":"J Med Virol [Internet]"},{"key":"5441_CR21","unstructured":"Adigun R, Goyal A, Hariz A (2022) Systemic sclerosis. StatPearls [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430875\/(cited 2023 Apr 15)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05441-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05441-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05441-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T07:04:07Z","timestamp":1697699047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05441-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":21,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5441"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05441-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"5 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ALT has received honoraria for advisory boards and speaking for Abbvie, Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB. EN has received speaker honoraria\/participated in advisory boards for Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, and Lilly and holds research grants from Pfizer and Lilly. HC has received grant support from Eli Lilly and UCB, consulting fees from Novartis, Eli Lilly, Orphazyme, Astra Zeneca, speaker for UCB, and Biogen. JD has received research funding from CSL Limited. JDP has undertaken consultancy work and\/or received speaker honoraria from Astra Zenaca, Boehringer Ingeheim, Sojournix Pharma, Permeatus Inc, Janssen and IsoMab Pharmaceuticals. MK has received speaker honoraria\/participated in advisory boards for Abbvie, Asahi-Kasei, Astellas, AstraZeneca, Boehringer-Ingelheim, Chugai, Corbus, Eisai, GSK, Horizon, Kissei, BML, Mochida, Nippon Shinyaku, Ono Pharmaceuticals, Tanabe-Mitsubishi. NZ has received speaker fees, advisory board fees, and research grants from Pfizer, Roche, Abbvie, Eli Lilly, NewBridge, Sanofi-Aventis, Boehringer Ingelheim, Janssen, and Pierre Fabre; none are related to this manuscript. OD has\/had consultancy relationship with and\/or has received research funding from and\/or has served as a speaker for the following companies in the area of potential treatments for systemic sclerosis and its complications in the last three calendar years: 4P-Pharma, Abbvie, Acceleron, Alcimed, Altavant, Amgen, AnaMar, Arxx, AstraZeneca, Baecon, Blade, Bayer, Boehringer Ingelheim, Corbus, CSL Behring, Galderma, Galapagos, Glenmark, Gossamer, iQvia, Horizon, Inventiva, Janssen, Kymera, Lupin, Medscape, Merck, Miltenyi Biotec, Mitsubishi Tanabe, Novartis, Prometheus, Redxpharma, Roivant, Sanofi and Topadur. Patent issued \u201cmir-29 for the treatment of systemic sclerosis\u201d (US8247389, EP2331143). RA has a consultancy relationship with and\/or has received research funding from the following companies: Bristol Myers-Squibb, Pfizer, Genentech, Octapharma, CSL Behring, Mallinckrodt, AstraZeneca, Corbus, Kezar, Abbvie, Janssen, Kyverna Alexion, Argenx, Q32, EMD-Serono, Boehringer Ingelheim, Roivant, Merck, Galapagos, Actigraph, Scipher, Horizon Therapeutics, Teva, Beigene, ANI Pharmaceuticals, Biogen, Nuvig, Capella Bioscience, and CabalettaBio. The rest of the authors have no conflict of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the Institutional Ethics Committee of SGPGIMS, Raebareli Road, Lucknow, 226014. Protocol number\/IEC Code: 2021-143-IP-EXP-39.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}